Detection of fetal RHD pseudogene (RHDΨ) and hybrid RHD-CE-Ds from RHD-negative pregnant women with a free DNA fetal kit

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 2653-2657

  Gunel, T ^a   Kalelioglu, I ^a   Gedikbasi, A ^b   Ermis, H ^a   Aydinli, K ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Kanuni Sultan Suleyman Public Hospital   (Turkey)

^c Medicus Health Center   (Turkey)

Author keywords

Cell free DNA; Maternal plasma; Prenatal diagnosis; RHD genotyping

Indexed keywords

RHESUS D ANTIGEN; DNA; RHO(D) ANTIGEN;

ALLELE; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD GROUP RHESUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; FETUS; FREE DNA FETAL KIT; GENOTYPE; HUMAN; HYBRID GENE; MATERNAL PLASMA; PREGNANCY; PSEUDOGENE; REAL TIME POLYMERASE CHAIN REACTION; RHD GENE; ADULT; BLOOD; CLINICAL TRIAL; GENETICS; MULTICENTER STUDY; PHYSIOLOGY;

ADULT; ALLELES; DNA; EXONS; FEMALE; FETUS; HUMANS; PREGNANCY; PSEUDOGENES; REAGENT KITS, DIAGNOSTIC; RH-HR BLOOD-GROUP SYSTEM;

EID: 84856418865     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.October.26.1     Document Type: Article

References (14)

1. Bennett PR, Le Van Kim C, Colin Y, Warwick RM, et al. (1993). Prenatal determination of fetal RhD type by DNA amplification. N. Engl. J. Med. 329: 607-610.
2. Bombard AT, Akolekar R, Farkas DH, VanAgtmael AL, et al. (2011). Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat. Diagn. 31: 802-808.
3. Chen JC, Lin TM, Chen YL, Wang YH, et al. (2004). RHD 1227A is an important genetic marker for RhD(el) individuals. Am. J. Clin. Pathol. 122: 193-198.
4. Chinen PA, Nardozza LM, Martinhago CD, Camano L, et al. (2010). Noninvasive determination of fetal rh blood group, D antigen status by cell-free DNA analysis in maternal plasma: experience in a Brazilian population. Am. J. Perinatol. 27: 759-762.
5. Daniels G, van der Schoot CE and Olsson ML (2007). Report of the second international workshop on molecular blood group genotyping. Vox Sang. 93: 83-88.
6. Daniels G, Finning K, Martin P and Massey E (2009). Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat. Diagn. 29: 101-107.
7. Faas BHW, Beckers EAM, Wildoer P, Lightart PC, et al. (1997). Molecular background of VS and weak C expression in blacks. Transfusion 37: 38-44.
8. Huang CH (1998). The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh(null) disease. J. Biol. Chem. 273: 2207-2213.
9. Rodrigues A, Rios M, Pellegrino J Jr, Costa FF, et al. (2002). Presence of the RHD pseudogene and the hybrid RHD-CE-D(s) gene in Brazilians with the D-negative phenotype. Braz. J. Med. Biol. Res. 35: 767-773.
10. Rouillac-Le SC, Puillandre P, Gillot R, Baulard C, et al. (2004). Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol. Diagn. 8: 23-31.
11. Rouillac-Le SC, Serazin V, Brossard Y, Oudin O, et al. (2007). Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. Transfus. Clin. Biol. 14: 572-577.
12. Scheffer P, van der Schoot C, Page-Christiaens G and de Haas M (2011). Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 118: 1340-1348.
13. Singleton BK, Green CA, Avent ND, Martin PG, et al. (2000). The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 95: 12-18.
14. Wagner FF and Flegel WA (2000). RHD gene deletion occurred in the Rhesus box. Blood 95: 3662-3668.